Deal with $3.02 million greenshoe conducted by Canaccord Genuity
By Devika Patel
Knoxville, Tenn., March 13 - Imris Inc. said it priced a $20.13 million public sale of stock with a $3.02 million greenshoe.
The company will sell 5.75 million common shares at $3.50 per share. The price per share is a 2.24% discount to the March 12 closing share price of $3.58.
Canaccord Genuity is the sole bookrunner.
Settlement is expected March 18.
Proceeds will be used for working capital and general corporate purposes, including commercialization activities of new products, research and development programs and working capital needs.
The Winnipeg, Man., company designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians.
| Issuer: | Imris Inc.
|
| Issue: | Common stock
|
| Amount: | $20,125,000
|
| Greenshoe: | $3,018,750
|
| Shares: | 5.75 million
|
| Price: | $3.50
|
| Warrants: | No
|
| Bookrunner: | Canaccord Genuity
|
| Co-manager: | Cowen and Co., LLC
|
| Pricing date: | March 13
|
| Settlement date: | March 18
|
| Stock symbol: | Nasdaq: IMRS
|
| Stock price: | $3.58 at close March 12
|
| Market capitalization: | $150.09 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
